The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve brain health, today announced the launch of its Brain Health Navigator program. The initiative led by the DAC Healthcare System Preparedness (DAC-SP) team will provide resources for patients and providers at six sites across the U.S. 

An international study published in the journal Nature Mental Health has identified three psychological profiles associated with different patterns of cognitive and brain decline in ageing. The study, which analysed more than 1,000 middle-aged and older adults, shows that the specific psychological characteristics of each profile may influence the risk of developing dementia, as well as aspects such as the speed of brain decline and sleep quality. These findings open new perspectives for the design of more personalized prevention strategies.

On January 15, the Brunei Ministry of Health (MOH), in partnership with BGI Genomics, launched the National Cervical Cancer Prevention and Control Program along with the 2025 National Guideline.

Pediatric ear, nose and throat (ENT) infections are highly prevalent and may require invasive surgical procedures to extract samples for identifying causal pathogens. However, this takes time and patients are prescribed broad-spectrum antibiotics until results are available. This leads to increased treatment costs and antibiotic-derived side-effects. A new Pediatric Investigation study examines the potential of a new diagnostic tool – microbial cell-free DNA (mcfDNA) testing – which may offer a simple alternative to traditional culturing methods.

A URV-led research team has identified molecules in the blood that link insulin resistance to an increased risk of developing Alzheimer’s disease. The molecules are a type of metabolite, that is, compounds produced by a set of chemical reactions that occur in living organisms, and their discovery may improve current methods for predicting Alzheimer’s disease. “We have opened up a new avenue in research into the prevention and treatment of this disease and its relationship with metabolic diseases such as obesity,” explained Mónica Bulló, a researcher in the URV’s Department of Biochemistry and Biotechnology.